Improved data dealing drives drug discovery Improved data dealing drives drug discovery: "Drug research and development is facing a major problem with the sheer influx of data generated, which threatens to further slow down productivity, if its management and interpretation is not efficiently dealt with.

That was the verdict from Sheryl Torr-Brown, worldwide safety sciences for Pfizer Global R&D, who was speaking at the Drug Discovery Technology Europe conference in London this week. Her concerns stemmed from the idea that pharmaceutical companies were not fully extracting and understanding relationships between genes and diseases or compounds and side effects - the fundamental essence in drug discovery."  ¶ 07:20